Bacterial acne foam - Foamix/Warner Chilcott
Latest Information Update: 05 Jun 2013
At a glance
- Originator Foamix; Warner Chilcott
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne
Most Recent Events
- 05 Jun 2013 No development reported - Preclinical for Acne in Israel (Topical)
- 12 Jan 2007 Preclinical trials in Acne in Israel (Topical)